About Midwest Chest Consultants
Clinical Trials at Midwest Chest Consultants
During the past decade, Midwest Chest Consultants conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Midwest Chest Consultants" #1 sponsor was "Sunovion" with 4 trials, followed by "Verona Pharma plc" with 2 trials
sponsored, "Genentech, Inc." with 1 trials sponsored, "Novartis" with 1 trials sponsored and "Sunovion Respiratory Development Inc."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Midwest Chest Consultants"
#1 collaborator was "Iqvia Pty Ltd" with 2 trials as a collaborator, "Knox Community Hospital" with 1 trials as a collaborator, "Midwest Chest Consultants" with 1 trials as a collaborator and "Riverside Regional Medical Center" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Midwest Chest Consultants
According to Clinical.Site data, the most researched conditions in "Midwest Chest Consultants" are
"Chronic Obstructive Pulmonary Disease" (6 trials), "Chronic Bronchitis" (2 trials), "Emphysema" (2 trials), "Asthma" (1 trials) and "COPD" (1 trials). Many other conditions were trialed in "Midwest Chest Consultants" in a lesser frequency.
Clinical Trials Intervention Types at Midwest Chest Consultants
Most popular intervention types in "Midwest Chest Consultants" are "Drug" (9 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Ensifentrine" (2 trials), "Salmeterol" (2 trials), "Arformoterol" (1 trials) and "Astegolimab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Midwest Chest Consultants
The vast majority of trials in "Midwest Chest Consultants" are
10 trials for "All" genders.
Clinical Trials Status at Midwest Chest Consultants
Currently, there are NaN active trials in "Midwest Chest Consultants".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Midwest Chest Consultants,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Midwest Chest Consultants, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".